| Name | Title | Contact Details |
|---|---|---|
Gregory Rash |
Head of Governance, Risk, and Compliance | Profile |
Marvin Larry |
Vice President, Chief Information Security Officer | Profile |
Pietr Lindahl |
Chief Information Security Officer | Profile |
BeFutur Biotechnologies is a Montreal, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Tridien Medical is a Pompano Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Enabling surgeons with clinically-relevant, innovative fluorescence imaging solutions to enhance the lives of patients and their surgeons, while reducing health care costs, is Novadaq’s global mission. SPY fluorescence imaging technology provides surgeons with real-time visualization, leading to improved outcomes and reduced costs without exposing the patient to harmful ionizing radiation or contrast dye toxicity. More than 130 peer-reviewed publications demonstrate that the use of SPY during complex surgery, leads to fewer post-operative complications and lower hospital costs. The SPY Imaging System is United States Food and Drug Administration (“FDA”) 510(k) cleared for use in seven surgical specialties. The endoscopic version of SPY called PINPOINT®, combines the capabilities of SPY Imaging with high definition (“HD”) visible light visualization offered by conventional endoscopes. Our unique business model of partnering with market-leading companies to drive adoption of our fluorescence imaging technology, while building our own commercial infrastructure is the cornerstone of our corporate strategy for growth.
Intrapace is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Procyrion is developing the first catheter-deployed circulatory assist device intended for long-term use. The Procyrion device will be the first minimally invasive tool for cardiologists to treat over 1M NYHA Class III and early class IV heart failure (HF) patients in the US who have few therapeutic options. In partnership with Texas Heart Institute, Procyrion is currently conducting preclinical testing of the Procyrion device.